is zepbound a glp-1 drug vs Semaglutide vs Wegovy: What's the Difference What Eli Lilly's new obesity

A report from Jefferies highlighted that while a healthier population is likely to reduce insurance premiums, this would only be seen in new business

Most recently, third-generation multi-agonists targeting complementary incretin receptors have demonstrated unprecedented metabolic efficacy in preclinical and investigational contexts, representing a paradigm shift in metabolic research

35 SGLT-1 is primarily responsible for glucose absorption in the gastrointestinal tract and only accounts for approximately 10% of glucose reabsorption in the kidney

The growing use of GLP-1 drugs in clinical practice makes these findings particularly significant